Trial Comparing Three Different Devices for Kidney Stone Removal During Percutaneous Surgery
- Conditions
- Kidney Stones
- Interventions
- Device: StonebreakerDevice: Lithoclast SelectDevice: Cyberwand
- Registration Number
- NCT00952315
- Lead Sponsor
- Indiana Kidney Stone Institute
- Brief Summary
The investigators plan to compare three different devices that are used to break up large kidney stones during surgery for removal to see if one is faster or more efficient than the others.
- Detailed Description
Large kidney stones can be removed by a surgical procedure where a small puncture is made through the back into the kidney (percutaneous nephrolithotomy or PNL) but the stones usually need to be broken into smaller pieces before they can be removed through the small surgical incision. There are a number of FDA approved devices commercially available used to break up the stones including pneumatic, ultrasonic, and a combination of the two. Each technology has advantages and disadvantages.
In the last few years there have been new, improved versions of these devices introduced. These improved versions have addressed previous issues of probes clogging or breaking and cumbersome handpiece design. These include the Cyberwand (Cybersonics, Erie, PA), a dual probe ultrasonic device, Swiss Lithoclast Select (EMS, Switzerland) combining the pneumatic and ultrasonic modalities, and a novel device by LMA (Gland, Switzerland) called the StoneBreakerTM, a portable pneumatic device powered by CO2 cartridges.
We propose to compare each of these devices in a randomized study to see if one is better than another at removing kidney stones quickly and efficiently.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 270
- Scheduled to undergo percutaneous nephrolithotomy for at least one kidney stone measuring 2 cm or greater
- Stone easily visible/measurable on plain abdominal imaging (KUB) or CT scan preoperatively
- Age 18 years or older
- Able to give informed consent
- Size of single largest stone less than 2 cm
- Pregnancy
- Active urinary tract infection
- Extracorporeal shockwave lithotripsy within the last three months
- Complex stone anticipating multiple access sites
- Stones that are not clearly able to be measured on KUB or CT scan
- Inability to give informed consent
- Age less than 18 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Stonebreaker Stonebreaker Stonebreaker will be used to break up the kidney stone. Duration will be timed and documented. Lithoclast Select Lithoclast Select Lithoclast Select will be used to breakup and remove kidney stone. Duration will be timed and documented. Cyberwand Cyberwand The dual probe Cyberwand device will be used to fragment and remove the kidney stone. Duration will be timed and documented.
- Primary Outcome Measures
Name Time Method Stone Clearance Time in mm2/Min collected intraoperatively from the time stone breakage begins to end of stone removal with a stone extraction basket Clearance rate was calculated by dividing the surface area of the targeted stone (mm2) by the total clearance time (min)
- Secondary Outcome Measures
Name Time Method Stone-free After First Procedure Post-operative Day 1 Number of participants deemed stone-free after initial stone-removal surgery
Secondary Procedure Required Within three days of initial procedure Number of participants who required a secondary kidney stone removal procedure
Ureteral Stent Placed Intra-operatively Participants requiring a ureteral stent to be placed after initial stone removal procedure
Length of Stay Post-operatively Number of days participants were in hospital. Operative day is Day 1.
Post-operative Complications Post-operative Days 2 and 3 Number of participants who experienced surgery-related post-op complications
EBL>400mL Intra-operatively Number of participants with an estimated blood loss greater than 400mL
Nephrostomy Tube Placed Intra-operatively Participants requiring a nephrostomy tube to be placed at the end of the initial stone removal procedure
Use of Other Device Intra-operatively Number of participants in which another stone breakage device was used in addition to the study-assigned lithotrite
RBC Transfusion Post-operatively <24 hours Number of participants who required a blood transfusion post-operatively
Trial Locations
- Locations (10)
Mayo Clinic Scottsdale
🇺🇸Phoenix, Arizona, United States
University of Wisconsin
🇺🇸Madison, Wisconsin, United States
IU Health Physicians Urology
🇺🇸Indianapolis, Indiana, United States
University of British Columbia
🇨🇦Vancouver, British Columbia, Canada
Mayo Clinic Rochester
🇺🇸Rochester, Minnesota, United States
Northwestern University
🇺🇸Chicago, Illinois, United States
Johns Hopkins
🇺🇸Baltimore, Maryland, United States
Duke University
🇺🇸Durham, North Carolina, United States
Vanderbilt University Medical Center
🇺🇸Nashville, Tennessee, United States
The University of Western Ontario
🇨🇦London, Ontario, Canada